NEW YORK, Aug. 14, 2019 /PRNewswire/ -- Inc. magazine today revealed that LoveBug Probiotics ranked No. 140 on its annual Inc. 5000 list, the most prestigious ranking of the nation's fastest-growing private companies. In addition, LoveBug Probiotics was featured in the top 500 companies. The list represents a unique look at the most successful compan

HONOLULU, Aug. 14, 2019 /PRNewswire/ -- Cardax, Inc. (OTCQB:CDXI) today filed its Quarterly Report on Form 10-Q for the quarter ended June 30, 2019.Recent developments include:CHASE Clinical Trial UpdateCardax plans a pre-specified interim review in September 2019 of the a

HONOLULU, Aug. 14, 2019 /PRNewswire/ -- Cardax, Inc. (OTCQB:CDXI) announced today that it filed a registration statement on Form S-1 with the Securities and Exchange Commission relating to a proposed follow-on public offering of up to $15 million of the Company's common stock and warrants. The number of securities to be offered and the price

Adjusted EBITDA up more than $5M (CDN) versus prior quarter;Company positioned to bring CBD products to U.S. market by end of fiscal 2020;Record harvest of over 40,000 kgKEY HIGHLIGHTSGenerated net revenue1 of $90.5 million in Q1 2020. Adjusted EBITDA of

PASADENA, Calif., Aug. 14, 2019 /PRNewswire/ -- Huntington Hospital announced today that local philanthropists, Terri and Jerry Kohl have made a gift of $7 million to support the expansion of its new Huntington Heart and Vascular Center.

LOS ANGELES, Aug. 14, 2019 /PRNewswire/ -- Eyesthetica partners have been listed in LA Magazine as the top doctors in Los Angeles for oculofacial plastic surgery. This prestigious award is given out once a year in a wide variety of medical disciplines to doctors who meet an extensive requirement list, including education, experience,

BALTIMORE, Aug. 14, 2019 /PRNewswire/ -- Leidos (NYSE: LDOS) and the Baltimore Ravens announce today they will team up to spread awareness about the ongoing opioid epi

WASHINGTON, Aug. 14, 2019 /PRNewswire/ -- The Alliance to Prevent Legionnaires' Disease, a national organization dedicated to reducing the occurrence of Legionnaires' Disease by promoting public research, education, best practices for water management, and advocating for comprehensive policies to combat and investigate this preventable disease, today issued the fo

BOSTON, Aug. 14, 2019 /PRNewswire/ -- Stealth BioTherapeutics Corp (NASDAQ: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization

SAN DIEGO, Aug. 14, 2019 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health, today reported financial results for its first quarter ended June 30, 2019 and provided an update on recent developments.Company UpdatesAethlon Medical, Inc. (Compa